N-Nitroso Edoxaban Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs.N-Nitroso Edoxaban Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 1 chemically represented as 5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridin-2-amine.Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 1 .We supply N-Nitroso Edoxaban Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143076 |
| CAS No | NA |
| Mol.F. | C22H23ClN8O |
| Mol.Wt. | 450.93 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143077 |
| CAS No | NA |
| Mol.F. | C26H30ClN7O2 |
| Mol.Wt. | 508.02 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143078 |
| CAS No | NA |
| Mol.F. | C23H24ClN7O2 |
| Mol.Wt. | 465.94 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143079 |
| CAS No | NA |
| Mol.F. | C22H21ClN10O |
| Mol.Wt. | 476.93 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143080 |
| CAS No | NA |
| Mol.F. | C22H21ClN6O2 |
| Mol.Wt. | 465.90 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143081 |
| CAS No | NA |
| Mol.F. | C24H23N5O6S |
| Mol.Wt. | 509.54 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143082 |
| CAS No | NA |
| Mol.F. | C24H21N5O6S |
| Mol.Wt. | 507.52 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143083 |
| CAS No | NA |
| Mol.F. | C31H29N5O7S |
| Mol.Wt. | 615.66 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143084 |
| CAS No | NA |
| Mol.F. | C24H25N5O5S |
| Mol.Wt. | 495.55 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143085 |
| CAS No | NA |
| Mol.F. | C23H21N5O6S |
| Mol.Wt. | 495.51 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143086 |
| CAS No | NA |
| Mol.F. | C14H11N3O6 |
| Mol.Wt. | 317.26 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143087 |
| CAS No | NA |
| Mol.F. | C9H8N2O5 |
| Mol.Wt. | 224.17 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143088 |
| CAS No | NA |
| Mol.F. | C11H12N2O5 |
| Mol.Wt. | 252.23 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143089 |
| CAS No | NA |
| Mol.F. | C8H6N2O5 |
| Mol.Wt. | 210.15 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143090 |
| CAS No | NA |
| Mol.F. | C10H10N2O5 |
| Mol.Wt. | 238.20 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143091 |
| CAS No | NA |
| Mol.F. | C13H16N2O9 |
| Mol.Wt. | 344.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |